For instance, the EML4-ALK fusion gene produces a novel F-circEA in non-small cell lung cancer (NSCLC), and the existence of F-circEA in sera makes it a promising liquid biopsy biomarker for monitoring the EML4-ALK fusion gene [45]. This evidence concerns the gene ALK and non-small cell lung carcinoma.